Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2015-09-08 16:52:03 |
Versijas komentārs | |
Teksts |
Olainfarm holds
Second Quarter 2015 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its second quarter 2015 investor
conference webinar scheduled on September 8, 2015 at 16:00
(EETWebinar will be hosted by the Member of the Management Board
Salvis Lapiņš. The presentation will be held in
English. During the webinar
Salvis Lapiņš informs about AS “Olainfarm” latest activities and
analyze the non-audited financial
results of the second quarter 2015. The enclosed
presentation will be presented during the
webinar.
What is
webinar? How to join the
webinar? To join the webinar, we invite you
to register via
ej.uz/OLF_2Q2015. You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. For more
information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information
prepared by: |
Pielikumi |